Preeclampsia as a life-threatening condition

Olenev A.S., Novikova V.A., Radzinsky V.E.

Peoples’ Friendship University of Russia, Moscow, Russia
Objective. To investigate clinical and laboratory criteria for the “reference point” of the progression of severe preeclampsia (PE) into a life-threatening condition with a different outcome (near miss or maternal death).
Subjects and methods. The investigators conducted a multicenter study conducted through an examination of 18,130 records of severe PE-complicated labors and deliveries. The study period was January 1, 2013 to December 31, 2018. There were 27 Moscow participating centers. A total of 122 delivery records were selected from women with PE and life-threatening conditions that led to near misses in 100 patients (a near miss group) and to maternal deaths in 22 women (a MD group).
Results. Within less than 24 hours, severe PE can develop into a life-threatening condition and result in MD in women aged 18-45 years after natural conception at 24 weeks’ gestation (up to 34 weeks in 50%), with a blood pressure of less than 160/100 mm Hg, the baseline level of creatinine from 33.0 to 349.5 μmol/L and its increase by 9.47 times, that of platelets from 10.0 to 362.010⁹/L and their increase by 0.04–1.0 time, that of bilirubin from 5.0 to 104.0 μmol/L and its increase by 1.56–24.63 times, that of ALT from 8.7 to 807.0 U/L and its increase by 1.0–318.8 times, that of AST from 15.0 to 1238.0 U/L and its increase by 1.68–429.53 times, that of LDH from 568,4 to 2315,0 U/L and its increase by 2.79–9.89 times; moreover, 22.73% of cases can have no pathognomonic complaints and have a satisfactory general condition.
Conclusion. PE should be considered as a condition with much more variability in outcomes, such as pre-stroke, pre-HELLP syndrome, pre-hepatic, prerenal, or multiple organ dysfunctions, etc. It is extremely difficult to predict MD. PE can manifest as a life-threatening condition within a few hours, possibly in the absence of elevated blood pressure. Critical liver failure competes by significance in the risks of MD with high blood pressure. The reference point from the diagnosis of PE to a life-threatening condition may be accompanied by the values of clinical and laboratory markers, which do not meet not only the criteria for near miss, but also severe PE. Timely delivery tactics is a fundamental measure for the prevention of life-threatening complications and MD.

Keywords

preeclampsia
life-threatening conditions
near miss
maternal death rates
gestational multiple organ dysfunction

References

  1. Радзинский В.Е., Фукс А.М. Акушерство. Учебник. М.: ГЭОТАР-Медиа; 2016. 1040 с. [Radzinsky V.E., Fuks A.M. Obstetrics. A textbook. Moscow: GEOTAR-Media; 2016.1040 p. (In Russian)].
  2. Evaluating the quality of care for severe pregnancy complications. The WHO near-miss approach for maternal health. World Health Organization; 2011. Available at: http://whqlibdoc.who.int/…/2011/9789241502221
  3. Федеральная служба государственной статистики. 2017. Доступно по: http://www.gks.ru/free_doc/doc_2017/bul_dr/edn/edn17-g.xlsx [Federal State Statistics Service. 2017. Available at: http://www.gks.ru/free_doc/doc_2017/bul_dr/edn/edn17-g.xlsx (In Russian)].
  4. Гипертензивные расстройства во время беременности, в родах и послеродовом периоде. Преэклампсия. Эклампсия. Клинические рекомендации (протокол лечения). М.; 2016. 72 с. [Hypertensive disorders during pregnancy, in labour and postlabour periods. Preeclampsia. Eclampsia. Clinical recommendations (protocol of treatment). Moscow; 2016. 72 p. (In Russian)].
  5. Организация медицинской эвакуации беременных женщин, рожениц и родильниц при неотложных состояниях. Клинические рекомендации (протокол лечения). Медицинский алфавит. 2016; 2[15(278)]: 50–3. [Organization of medical evacuation of pregnant women, women in childbirth and parturient women in emergency conditions. Clinical recommendations (treatment protocol). Meditsinskii alfavit/Medical alphabet. 2016; 2[15 (278)]: 50–3. (In Russian)].
  6. Poon L.C., Shennan A., Hyett J.A., Kapur A., Hadar E., Divakar H. et al. The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. Int. J. Gynaecol. Obstet. 2019; 145(Suppl. 1): 1–33. https://doi.org/10.1002/ijgo.12802.
  7. ACOG Practice Bulletin No. 202: Gestational hypertension and preeclampsia. Obstet. Gynecol. 2019; 133(1): e1-25. https://doi.org/10.1097/AOG.0000000000003018.
  8. 11th Revision of the International Classification of Diseases (ICD- 11). Geneva: World Health Organization; 2018.
  9. Сидорова И.С., Никитина Н.А., Унанян А.Л. Преэклампсия и снижение материнской смертности в России. Акушерство и гинекология. 2018; 1: 107–12. Ihttps://dx.doi.org/10.18565/aig.2018.1.107-112. [Sidorova I.S., Nikitina N.A., Unanyan A.L. Preeclampsia and a decrease in maternal mortality in Russia. Akusherstvo i ginekologiya/Obstetrics and Gynecology. 2018; (1): 107–12. (In Russian)]. https: //dx.doi.org/10.18565/aig.2018.1.107-112.
  10. Сидорова И.С., Никитина Н.А. Преэклампсия как гестационный иммунокомплексный комплементоопосредованный эндотелиоз. Российский вестник акушера-гинеколога. 2019; 19(1): 5–11. https://doi.org/10.17116/rosakush2019190115. [Sidorova I.S., Nikitina N.A. Preeclampsia as a gestational immunocomplex complement-mediated endotheliosis. Rossiiskii vestnik akushera-ginekologa /Russian Bulletin of the Obstetrician-Gynecologist. 2019 19(1): 5–11. (In Russian)]. https://doi.org/10.17116/rosakush2019190115.
  11. Sibai B.M., Stella C.L. Diagnosis and management of atypical preeclampsia-eclampsia. Am. J. Obstet. Gynecol. 2009; 200(5): 481. e1–7. https://doi.org/10.1016/j.ajog.2008.07.048.
  12. Савельева Г.М., Шалина Р.И., Коноплянников А.Г., Симухина М.А. Преэклампсия и эклампсия: новые подходы к диагностике и оценке степени тяжести. Акушерство и гинекология: новости, мнения, обучение. 2018; 6(4): 25–30. https://doi.org/10.24411/2303-9698-2018-14002. [Savelyeva G.M., Shalina R.I., Konoplyannikov A.G., Simukhina M.A. Preeclampsia and eclampsia: new approaches to the diagnosis and assessment of severity. Akusherstvo i ginekologiya: novosti, mneniya, obuchenie /Obstetrics and Gynecology: News, Opinions, Training. 2018; 6(4): 25–30. (In Russian)]. https://doi.org/10.24411/2303-9698-2018-14002.
  13. Berhan Y. No hypertensive disorder of pregnancy; No preeclampsia-eclampsia; No gestational hypertension; No hellp syndrome. Vascular disorder of pregnancy speaks for all. Ethiop. J. Health Sci. 2016; 26(2): 177–86.
  14. Михалёва Л.М., Грачева Н.А., Бирюков А.Е. Клинико-анатомические аспекты преэклампсии: современные особенности течения. Архив патологии. 2018; 80(2): 11–7. https://doi.org/10.17116/patol201880211-17. [Mikhaleva L.M., Gracheva N.A., Biryukov A.E. Clinical and anatomical aspects of preeclampsia: current features of the course. Arkhiv patologii/Pathology Archive. 2018; 80(2): 11–7. (In Russian)]. https://doi.org/10.17116/patol201880211-17.
  15. Rana S., Lemoine E., Granger J., Karumanchi S. Preeclampsia: pathophysiology, challenges, and perspectives. Circ. Res. 2019; 124(7): 1094–112. https://doi.org/10.1161/CIRCRESAHA.118.313276.
  16. Мамонтова И.К., Шевлякова Т.В., Петрова Е.И. «Near miss» в акушерстве: место в оценке технологий здравоохранения, подходы к классификации и оценке. Фармакоэкономика. Современная фармакоэкономика и фармакоэпидемиология. 2018; 12(4): 92–6. https://doi.org/10.17749/2313-7347.2018.11.4.092-096. [Mamontova I.K., Shevlyakova T.V., Petrova E.I. “Near miss” in obstetrics: a place in the evaluation of healthcare technologies, approaches to classification and evaluation. Pharmacoeconomics. Modern pharmacoeconomics and pharmacoepidemiology. 2018; 12(4): 92–6 (In Russian)]. . https://doi.org/92-6.10.17749 / 2313-7347.2018.11.4.092-096.
  17. Samy El-Agwany A., Abdelsadek A. Abdelhadi. A rare case of normotensive HELLP syndrome complicated with massive ascites: Spontaneous resolution. Egypt. J. Anaesth. 2016; 32(1): 155–8. https://doi.org/10.1016/j.egja.2015.09.003
  18. Leeman L., Dresang L.T., Fontaine P. Hypertensive disorders of pregnancy. Am. Fam. Physician. 2016; 93(2): 121–7. PMID: 26926408
  19. Basit S., Wohlfahrt J., Boyd H.A. Pre-eclampsia and risk of dementia later in life: nationwide cohort study. BMJ. 2018; 363: k4109. https://doi.org/10.1136/bmj.k4109.
  20. Brown M.C., Best K.E., Pearce M.S., Waugh J., Robson S.C., Bell R. Cardiovascular disease risk in women with pre-eclampsia: systematic review and meta-analysis. Eur. J. Epidemiol. 2013; 28(1): 1–19. https://doi.org/10.1007/s10654-013-9762-6.
  21. Новикова В.А., Юсупова З.С., Шаповалова О.А., Хорольский В.А. Обоснование контроля реконвалесценции и индивидуальной реабилитации у женщин, перенесших тяжелую преэклампсию. Кубанский научный медицинский вестник. 2018; 25(3): 73–81. [Novikova V.A., Yusupova Z.S., Shapovalova O.A., Khorolsky V.A. Justification of the control of reconvalescence and individual rehabilitation in women who underwent severe preeclampsia. Kubanskii nauchnyi meditsinskii vestnik. 2018; 25(3): 73–81. https://doi.org/10.25207 / 1608–6228-2018-25-3-73-81 (In Russian)].
  22. Кирсанова Т.В., Виноградова М.А., Колыванова А.И., Шмаков Р.Г. HELLP-синдром: клинико-лабораторные особенности и дисбаланс плацентарных факторов ангиогенеза. Акушерство и гинекология. 2018; 7: 46–55.[Kirsanova T.V., Vinogradova M.A., Kolyvanova A.I., Shmakov R.G. HELLP syndrome: clinical and laboratory features and an imbalance of placental angiogenesis factors. Akusherstvo i ginekologiya/Obstetrics and Gynecology. 2018; 7: 46–55. (In Russian)]. https://dx.doi.org/10.18565/aig.2018.7.46–55

Received 23.01.2020

Accepted 07.02.2020

About the Authors

Anton S. Olenev, PhD, Associate Professor of the Department of Obstetrics and Gynecology with a course in Perinatology, Medical Institute, Federal State-Autonomous Educational Institution of Higher Education “Russian University of Peoples Friendship” of the Ministry of Science and Higher Education of the Russian Federation (RUDN) Chief freelance specialist in obstetrics and gynecology in Moscow, head of the Perinatal Center branch of the City Clinical Hospital No. 24 of the DZM.
Telephone: +7 (495) 613-45-09. E-mail: olenevAS@zdrav.mos.ru.
Address: 117198, Moscow, st. Miklouho-Maclay, 6.
Vladislava A. Novikova, MD, Professor of the Department of Obstetrics and Gynecology with a course in Perinatology, Medical Institute, Federal State Autonomous Educational Institution of Higher Education “Russian University of Peoples Friendship” of the Ministry of Science and Higher Education of the Russian Federation (RUDN). Phone: 8 (499) 137-48-81. E-mail: vladislavan@mail.ru.
Address: 117198, Moscow, st. Miklouho-Maclay, 6.
Victor E. Radzinsky, MD, professor, Head of the Department of Obstetrics and Gynecology with a course in Perinatology, Medical Institute, Federal State Autonomous Educational Institution of Higher Education “Peoples’ Friendship University of Russia” of the Ministry of Science and Higher Education of the Russian Federation
Telephone: +7 (499) 137-48-81. E-mail: kafedra-aig@mail.ru. Address: 117198, Moscow, st. Miklouho-Maclay, 6.

For citations: Olenev A.S., Novikova V.A., Radzinsky V.E. Pre-eclampsia as a life-threatening condition.
Akusherstvo i Ginekologiya/ Obstetrics and gynecology. 2020; 3: 48-57. (In Russian).
https://dx.doi.org/10.18565/aig.2020.3. 48-57

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.